Benitec Biopharma Ltd ADR (BNTC NASDAQ) stock market data APIs
$13.8384
0.18(1.3%)
as of September 12, 2025
Try our APIs with
free plan!
Benitec Biopharma Ltd ADR Financial Data Overview
Price chart is built with
Anychart
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference-based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. Benitec Biopharma Inc. was incorporated in 1995 and is headquartered in Hayward, California.
Prev. Close
13.8384
Open
14.0153
High
13.9776
Low
13.7342
52 wk Range
8.2-17.15
Market Cap
364 M
Shares Outstanding
26 251 K
Revenue
7 000
EPS
-0.24
Beta
0.429
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Benitec Biopharma Ltd ADR (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Benitec Biopharma Ltd ADR data using free add-ons & libraries
Get Benitec Biopharma Ltd ADR Fundamental Data
Benitec Biopharma Ltd ADR Fundamental data includes:
- Net Revenue: 7 000
- EBITDA: -30 059 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-14
- EPS/Forecast: -0.35
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Benitec Biopharma Ltd ADR News
New
Amkor Technology Reaches Analyst Target Price
In recent trading, shares of Amkor Technology Inc. (Symbol: AMKR) have crossed above the average analyst 12-month target price of $41.00, changing hands for $41.19/share. When a stock reaches the tar...
Benitec Biopharma's SWOT analysis: gene therapy stock shows promise amid clinical progress
Benitec Biopharma Inc. (NASDAQ:BNTC), a biotechnology company specializing in gene therapies, has been making significant strides in its clinical development programs, particularly with its lead cand...
Benitec BioPharma stock maintains Market Outperform rating at JMP
Investing.com - Benitec BioPharma (NASDAQ:BNTC), currently trading at $13.84, maintained its Market Outperform rating and $20.00 price target in a research note from JMP Securities on Thursday. Accord...
Cowen initiates Benitec BioPharma stock with Buy rating on OPMD treatment
Investing.com - TD Cowen initiated coverage on Benitec BioPharma (NASDAQ:BNTC) with a Buy rating on Monday. The clinical-stage biotechnology company, currently valued at $346 million, has seen its sha...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
